Elsevier

Joint Bone Spine

Volume 79, Issue 2, March 2012, Pages 166-169
Joint Bone Spine

Original article
A controlled trial of the benefits of ultrasound-guided steroid injection for shoulder pain

https://doi.org/10.1016/j.jbspin.2011.04.001Get rights and content

Abstract

Objectives

We studied the value of ultrasound (US) to define shoulder pathology and guide local steroid injection in comparison with a standard injection in the management of the acute painful shoulder.

Methods

Seventy consecutive patients with acute shoulder pain were assessed clinically and by US. Patients were randomized to receive either a standard subacromial infiltration of 7 mg of betamethasone or a US-guided injection according to the US diagnosis. Follow-up evaluations were performed by an independent assessor who was blinded to the results of the initial US and clinical assessments.

Results

Sixty-seven patients completed the study. Both groups showed a significant reduction in both daytime and night pain compared to baseline. The US injection group had significantly less pain at rest at 2 and 6 weeks (NRS: 1.6 vs 3.3, P < 0.005; 3 vs 4.2, P < 0.04). The percentage of good responders was significantly higher in US group at 2 weeks, (81% vs 54%, P < 0.005) and 6 weeks (64% vs 38%, P < 0.05). At 2 and 6 weeks, responder rate and activity pain scores as well as Constant score were in favour of US, though did not reach statistical significance.

Conclusion

Local steroid injection for shoulder pain leads to significant improvements in pain and function for up to 12 weeks. An US examination to define the origin of shoulder pain as well as to guide injection provides significant additional benefits for up to 6 weeks. We recommend routine US examination as part of the management of acute shoulder pain.

Section snippets

Patients

Patients are recruited from three Swiss rheumatology centres between December 2008 and May 2010. Inclusion criteria are patients over age of 18 with shoulder pain that did not respond to NSAID or physiotherapy. Exclusion criteria included history of inflammatory arthritis, radiological gleno-humeral osteoarthritis and previous steroid local injection within 12 weeks. Patients signed an informed consent and were assigned treatment groups by random-number sequence. All patients underwent shoulder

Results

The selection of patients for this study is shown in Fig. 1. Only half of the 143 patients who underwent an initial evaluation could be randomized. Of the 70 randomized patients, 67 completed the study. Two patients did not respond to the two weeks phone call and the next follow-up evaluations, one received a second steroid local injection within the 2 first weeks. Baseline demographics are summarized in Table 1. The two groups were similar with respect to sex, age, pain duration, the number of

Discussion

Our study confirms that local corticosteroid injection produces a significant reduction in shoulder pain in the short term (up to 2 weeks) in all patients, and in addition, US-guided injection to the site of shoulder pathology gave a better result than injection into the subacromial bursa in a blinded fashion. This finding was particular relevant in the reduction of night time shoulder pain at week 2 and week 6, as this most likely has an inflammatory component, and the identification of the

Disclosure of interest

The authors declare that they have no conflicts of interest concerning this article.

References (17)

There are more references available in the full text version of this article.

Cited by (40)

  • Ultrasound Guidance Is Not Superior in Subacromial Bursa and Intraarticular Injections but Superior in Bicipital Groove: A Meta-analysis of Randomized Controlled Trials

    2022, Arthroscopy - Journal of Arthroscopic and Related Surgery
    Citation Excerpt :

    Only one study did not report sex distribution and the mean age of patients was the youngest.34 All the studies included patients with shoulder pathology, including tendonitis,26,31,33,34 tendon rupture and tears,10,24,25,31 bursitis,10,24,25,27,31, tendinosis,24 fluid accumulation,10,24 synovitis,10,25 tendon calcifications,10,24 tendonitis,10 adhesive capsulitis/frozen shoulder,23,36 acromioclavicular degeneration,24 impingement syndrome,24,25,29-31,35 periarthritis,32 and shoulder arthritis.32 Only 1 study reported stiffness of the shoulder joint due to various causes28 (Table 1).

  • Ultrasound guided versus landmark guided corticosteroid injection in patients with rotator cuff syndrome: Randomised controlled trial

    2018, Journal of Clinical Orthopaedics and Trauma
    Citation Excerpt :

    Ucucncu19 performed a study in which no specific shoulder pain cases were taken which showed Mean increment of 32.2 in US guided group and 12.2 in other group whereas this study was about specific rotator cuff syndrome. Zufferey et al.20 stated that clinical difference is evaluated at a difference of 16 to 20 points in Constant Score. In our study 11 patients in group 1 and 12 patients in group 2 achieved more than 16 points increment at 3 months follow up when compared from the baseline.

  • Musculoskeletal interventional procedures: With or without imaging guidance?

    2016, Best Practice and Research: Clinical Rheumatology
    Citation Excerpt :

    There is not enough data to confirm that USGIs are more accurate than LMGIs, and further research is required to clarify this (Table 2). Five studies have evaluated the efficacy of USGIs and LMGIs into the subacromial space, and they all showed better outcomes for the USGI procedures in the short term [34–38]. However, two additional studies found that there is no difference in efficacy between accurate and inaccurate injections [27,29].

  • Ultrasound-guided versus blind subacromial-subdeltoid bursa injection in adults with shoulder pain: A systematic review and meta-analysis

    2015, Seminars in Arthritis and Rheumatism
    Citation Excerpt :

    Characteristics of the enrolled studies are described in Table 1. Six studies assessed pain using a pain score [13–15,17–19] and two assessed SDQ score [15,18] at 6 weeks after injection. The analysis indicated a statistically significant decreased VAS and SDQ score difference between USG and LMG groups at this follow-up period in favor of USG [MD = 1.19, 95% CI (0.39, 1.98), P = 0.003 and MD = 5.01, 95% CI (1.82, 8.19), P = 0.02, respectively, Figs. 2 and 3].

View all citing articles on Scopus
View full text